Investigating the patterns of treatment failure in patients with advanced stage III and IV melanoma receiving adjuvant therapy

被引：0
|
作者：
Alimohamed, Asrar Iqbal
Lawless, Aleigha
Michaud, William
Sharova, Tatyana
Rauwerdink, Daan
Dedeilia, Aikaterini
Tarantino, Giuseppe
Sade-Feldman, Moshe
Liu, David
Boland, Genevieve Marie
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Gen Hosp, Ctr Canc, Surg Oncol, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21532
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy
    Jacques, S. K.
    McKeown, J.
    Grover, P.
    Park, B.
    Zaremba, A.
    Dimitriou, F.
    Rashid, M. F. Harunal
    Namikawa, K.
    Mooradian, M.
    Placzke, J.
    Allayous, C.
    Mehmi, I.
    DePalo, D.
    Wicky, A.
    Schwarze, J. K.
    Nakamura, Y.
    Benannoune, N.
    Menzies, A. M.
    Lo, S. N.
    Carlino, M. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S915 - S916
  • [22] Neoadjuvant treatment for stage III and IV cutaneous melanoma
    Gorry, Claire
    McCullagh, Laura
    O'Donnell, Helen
    Barrett, Sarah
    Schmitz, Susanne
    Barry, Michael
    Curtin, Kay
    Beausang, Eamon
    Barry, Rupert
    Coyne, Imelda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [23] Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients
    Tauceri, Francesca
    Mura, Gianni
    Roseano, Mauro
    Framarini, Massimo
    Ridolfi, Laura
    Verdecchia, Giorgio M.
    LANGENBECKS ARCHIVES OF SURGERY, 2009, 394 (06) : 1079 - 1084
  • [24] Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients
    Francesca Tauceri
    Gianni Mura
    Mauro Roseano
    Massimo Framarini
    Laura Ridolfi
    Giorgio M. Verdecchia
    Langenbeck's Archives of Surgery, 2009, 394 : 1079 - 1084
  • [25] Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1845 - 1855
  • [26] Frontiers in adjuvant therapy in stage II-III melanoma
    Eggermont, AMM
    TUMORI JOURNAL, 2001, 87 (04): : S60 - S63
  • [27] Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Boer, A. M. Stevense-den
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [28] TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY
    Bedane, C.
    Leccia, M. T.
    Sassolas, B.
    Mansard, S.
    Guillot, B.
    Mortier, L.
    Robert, C.
    Saiag, P.
    Truchetet, F.
    Oukessou, A.
    Bregman, B.
    Lebbe, C.
    VALUE IN HEALTH, 2010, 13 (07) : A273 - A273
  • [29] Milestones in the Treatment of malignant Melanoma Nivolumab in the Adjuvant and as a Combination Therapy with Ipilimumab in Patients with advanced Melanoma
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (7-8) : 414 - 415
  • [30] Prognostic value of serum YKL-40 in stage IIB-III melanoma patients receiving adjuvant interferon therapy.
    Krogh, M.
    Christensen, I. J.
    Bouwhuis, M.
    Johansen, J. S.
    Schmidt, H.
    Hansson, J.
    Aamdal, S.
    Testori, A.
    Eggermont, A. M.
    Bastholt, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345